In patients with RET-fusion positive NSCLC with symptomatic brain metastases, would you consider starting selpercatinib/pralsetinib upfront or would you proceed with whole brain radiation with TKI to follow?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Kaiser Permanente
What about symptomatic brain mets with vasogenic e...
Medical Oncologist at Cedars-Sinai Medical Center
One must use their judgement but if brain metastas...
Sign in or Register to read more